The statistic shows the projected distribution of the global rare disease diagnostics market in 2018 and 2025, by end user. In 2018, the hospital laboratories were expected to have a share of around 36.4 percent among all end users.
Global rare disease diagnostics market share in 2018 and 2025, by end user
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BIS Research. (December 1, 2018). Global rare disease diagnostics market share in 2018 and 2025, by end user [Graph]. In Statista. Retrieved December 30, 2024, from https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/
BIS Research. "Global rare disease diagnostics market share in 2018 and 2025, by end user." Chart. December 1, 2018. Statista. Accessed December 30, 2024. https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/
BIS Research. (2018). Global rare disease diagnostics market share in 2018 and 2025, by end user. Statista. Statista Inc.. Accessed: December 30, 2024. https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/
BIS Research. "Global Rare Disease Diagnostics Market Share in 2018 and 2025, by End User." Statista, Statista Inc., 1 Dec 2018, https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/
BIS Research, Global rare disease diagnostics market share in 2018 and 2025, by end user Statista, https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/ (last visited December 30, 2024)
Global rare disease diagnostics market share in 2018 and 2025, by end user [Graph], BIS Research, December 1, 2018. [Online]. Available: https://www.statista.com/statistics/971485/rare-disease-diagnostics-market-share-by-end-user/